These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 39063142)
1. The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status. Hawryłkowicz V; Stasiewicz B; Maciejewska D; Sołek-Pastuszka J; Komorniak N; Skonieczna-Żydecka K; Martynova-Van Kley A; Stachowska E Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063142 [TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827 [TBL] [Abstract][Full Text] [Related]
3. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680 [TBL] [Abstract][Full Text] [Related]
4. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P Front Immunol; 2020; 11():607734. PubMed ID: 33569053 [No Abstract] [Full Text] [Related]
5. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Root-Bernstein R Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738 [TBL] [Abstract][Full Text] [Related]
6. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Iwasaki M; Saito J; Zhao H; Sakamoto A; Hirota K; Ma D Inflammation; 2021 Feb; 44(1):13-34. PubMed ID: 33029758 [TBL] [Abstract][Full Text] [Related]
7. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way. Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220 [TBL] [Abstract][Full Text] [Related]
8. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. Suárez-Reyes A; Villegas-Valverde CA MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614 [TBL] [Abstract][Full Text] [Related]
9. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE Front Immunol; 2021; 12():749291. PubMed ID: 34867978 [TBL] [Abstract][Full Text] [Related]
10. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR Front Immunol; 2022; 13():888897. PubMed ID: 35663932 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients. Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T Front Immunol; 2021; 12():629193. PubMed ID: 33732251 [TBL] [Abstract][Full Text] [Related]
12. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Pum A; Ennemoser M; Adage T; Kungl AJ Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810 [TBL] [Abstract][Full Text] [Related]
13. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. Wang J; Jiang M; Chen X; Montaner LJ J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467 [TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19. Gharajeh NH; Pourjafar H; Derakhshanian H; Mohammadi H; Barzegari A; Eslami S Curr Pharm Biotechnol; 2022; 23(15):1837-1850. PubMed ID: 35379123 [TBL] [Abstract][Full Text] [Related]
15. Roles of the gut microbiota in severe SARS-CoV-2 infection. Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164 [TBL] [Abstract][Full Text] [Related]
16. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
17. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Wang M; Zhang Y; Li C; Chang W; Zhang L Front Immunol; 2023; 14():1180336. PubMed ID: 37205106 [TBL] [Abstract][Full Text] [Related]
18. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications. Machado C; González-Quevedo A MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537 [TBL] [Abstract][Full Text] [Related]
19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
20. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection. Ahmed F Front Immunol; 2020; 11():590459. PubMed ID: 33362771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]